CelLBxHealth presents proof-of-concept study using Roche Tissue Diagnostics' workflow at world-leading drug development ...
Q3 2025 Earnings Call Transcript November 3, 2025 BioNTech SE misses on earnings expectations. Reported EPS is $-0.14 EPS, ...
Expert consensus predicts integration of CTC testing into routine clinical practice within 5 years 2. CTCs provide distinct and impactful information that is not captured by circulating tumour DNA ...
Tissue-engineered and chip-based models are changing how scientists study early cancer, leading to more accurate and humane ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback